Now Is the Time to Get In Early on This Company Before It Makes a Major Announcement

Original post

If the results are positive – as we believe they will be – we are going to see a tiny $7 company go absolutely vertical…

Already, biotech insiders are swarming…

In fact, they’ve grabbed up nearly 9 out of 10 available shares.

It won’t take much buying pressure to push this tiny company to $14… $28… even $56 a share…

And now, a $900 billion Swiss investment firm – banker to over half the world’s billionaires – has just ramped up its stake by over 4,000%!

FRENZY: Phase 3 results could spark 72,500% revenue explosion starting Sept. 30 – click here now.

The writing is on the wall, and the time for action is now…

When you add it all up, a conservative projection sees this company experiencing a 72,500% revenue explosion.

Again, insiders and institutions have snapped up nearly 90% of available shares, and you need to move fast to avoid missing out.

Phase 3 results are expected any day now and are due by Sept. 30.

And because almost 90% of the available shares are already spoken for…

… heavy institutional buying could push this tiny $7 stock out of reach before the phase 3 results are even released.

In other words, you need to move fast to avoid missing out on your shot.

So let’s do this…

Follow Money Morning on FacebookTwitter, and LinkedIn.

Join the conversation. Click here to jump to comments…